UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN C000000423
Receipt No. R000000507
Official scientific title of the study Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantation
Date of disclosure of the study information 2006/06/01
Last modified on 2016/06/02 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantation
Title of the study (Brief title) Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD
Region
Japan

Condition
Condition refractoty acute GVHD after stem cell transplantation
Classification by specialty
Hematology and clinical oncology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of mesenchymal stem cells for treatment of refractory acute GVHD
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes GVHD score
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Intravenous injection of mesenchymal stem cells
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >
Gender Male and Female
Key inclusion criteria 1) after stem cell transplantation
2) acute GVHD (grade III-IV)
3) refractory or relapsed acute GVHD after steroid therapy
4) written informed consent
5) HLA matched or one locus mismatched donor
Key exclusion criteria 1) in relapse disease status
2) in unconsciousness
3) in severe infection
Target sample size 5

Research contact person
Name of lead principal investigator Keiya Ozawa
Organization Jichi Medical University
Division name Division of Hematology
Address 3311-1 Yakushiji, Shimotsuke-shi, Tochigi
TEL 0285-58-7353
Email

Public contact
Name of contact person Kazuya Sato
Organization Jichi Medical University
Division name Division of Hematology
Address 3311-1 Yakushiji, Shimotsuke-shi, Tochigi
TEL 0285-58-7353
Homepage URL
Email kazuya@jichi.ac.jp

Sponsor
Institute Jichi Medical University, Department of Medicine, Division of Hematology
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Jichi Medical University, Department of Medicine, Division of Hematology
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2006 Year 06 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2006 Year 01 Month 16 Day
Anticipated trial start date
2006 Year 06 Month 01 Day
Last follow-up date
2009 Year 05 Month 01 Day
Date of closure to data entry
2009 Year 06 Month 01 Day
Date trial data considered complete
2009 Year 07 Month 01 Day
Date analysis concluded
2009 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2006 Year 05 Month 29 Day
Last modified on
2016 Year 06 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000000507